Enanta Pharmaceuticals, Inc. (ENTA)
12.48
+0.38
(+3.18%)
USD |
NASDAQ |
Oct 09, 16:00
12.48
0.00 (0.00%)
After-Hours: 16:58
Enanta Pharmaceuticals Total Return Level : 12.10 for Oct. 8, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| October 08, 2026 | 12.10 |
| October 07, 2026 | 12.37 |
| October 06, 2026 | 12.17 |
| October 05, 2026 | 12.60 |
| October 02, 2026 | 12.96 |
| October 01, 2026 | 12.84 |
| September 30, 2026 | 13.18 |
| September 29, 2026 | 12.64 |
| September 28, 2026 | 12.62 |
| September 25, 2026 | 11.88 |
| September 24, 2026 | 12.00 |
| September 23, 2026 | 11.95 |
| September 22, 2026 | 12.42 |
| September 21, 2026 | 12.11 |
| September 18, 2026 | 12.20 |
| September 17, 2026 | 12.52 |
| September 16, 2026 | 12.70 |
| September 15, 2026 | 12.29 |
| September 14, 2026 | 13.12 |
| September 11, 2026 | 12.96 |
| September 10, 2026 | 12.70 |
| September 09, 2026 | 13.24 |
| September 08, 2026 | 13.50 |
| September 04, 2026 | 14.08 |
| September 03, 2026 | 14.02 |
| Date | Value |
|---|---|
| September 02, 2026 | 14.09 |
| September 01, 2026 | 13.51 |
| August 31, 2026 | 13.33 |
| August 28, 2026 | 13.60 |
| August 27, 2026 | 13.80 |
| August 26, 2026 | 14.15 |
| August 25, 2026 | 14.08 |
| August 24, 2026 | 14.10 |
| August 21, 2026 | 13.47 |
| August 20, 2026 | 13.13 |
| August 19, 2026 | 13.51 |
| August 18, 2026 | 13.30 |
| August 17, 2026 | 12.83 |
| August 14, 2026 | 13.16 |
| August 13, 2026 | 13.44 |
| August 12, 2026 | 13.50 |
| August 11, 2026 | 13.52 |
| August 10, 2026 | 13.81 |
| August 07, 2026 | 13.77 |
| August 06, 2026 | 13.34 |
| August 05, 2026 | 13.22 |
| August 04, 2026 | 13.32 |
| August 03, 2026 | 12.95 |
| July 31, 2026 | 12.60 |
| July 30, 2026 | 13.00 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Coherus Oncology, Inc. | 1.07 |
| BridgeBio Pharma, Inc. | 65.04 |
| RenovoRx, Inc. | 1.33 |
| ACADIA Pharmaceuticals, Inc. | 19.58 |
| Alnylam Pharmaceuticals, Inc. | 224.53 |